Related Experiment Video
Updated: Feb 20, 2026

Development of Leishmania Species Strains with Constitutive Expression of eGFP
Published on: April 21, 2023
Systematic Review into Diagnostics for Post-Kala-Azar Dermal Leishmaniasis (PKDL)
Emily R Adams1, Inge Versteeg, Mariska M G Leeflang
1Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK ; Royal Tropical Institute, KIT Biomedical Research, 1105 AZ Amsterdam, The Netherlands.
Accurate diagnosis of post-kala-azar dermal leishmaniasis (PKDL) is crucial. Current diagnostic tests lack sufficient evidence of accuracy, necessitating improved research for reliable identification and treatment.
Area of Science:
- Medical Parasitology
- Infectious Diseases
- Diagnostic Accuracy Research
Background:
- Post-kala-azar dermal leishmaniasis (PKDL) diagnosis is critical due to lengthy, toxic treatments and its role as a reservoir for visceral leishmaniasis (VL).
- Existing diagnostic methods for PKDL require rigorous evaluation to ensure reliable identification and management.
Purpose of the Study:
- To systematically review and summarize the published literature on the diagnostic accuracy of various tests for PKDL.
- To identify gaps in current research and recommend future directions for PKDL diagnostic test evaluation.
Main Methods:
- A comprehensive literature search was conducted in Medline for studies assessing the diagnostic accuracy of any test for PKDL.
- Study quality was evaluated using the QUADAS-2 tool.
- Data from 21 articles, encompassing 43 distinct studies, were extracted, covering serological, molecular, microscopy, and culture-based tests.
Main Results:
- A limited number of studies provided valid diagnostic accuracy estimates, with many employing case-control designs or suboptimal reference standards.
- Significant heterogeneity was observed across studies, particularly in the reference standards used, precluding meta-analysis.
- Twenty-seven studies assessed serological tests (rK39 dipstick, ELISA, DAT, leishmanin), six evaluated molecular tests, eight used microscopy, and two employed cultures.
Conclusions:
- There is a critical need for well-designed diagnostic accuracy trials for PKDL.
- Future research should concurrently evaluate all available diagnostic modalities, including clinical signs, serological, antigen, molecular, and parasitological tests.
- Statistical modeling may be valuable for evaluating diagnostics in the absence of a definitive gold standard.
More Related Videos
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
11:36Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012